Nutritional management of recurrent colic and colonic impactions

Although diagnosis and treatment of horses with colic have improved in the last 30 years, horses with recurrent colic can be a diagnostic and management challenge for both owners and veterinarians, and colic remains a high priority health concern of owners (Mellor et al. 2001 ). Nutritional management of these cases is often based on previous experience combined with recommendations from the evidence‐based literature. This review will briefly summarise the aetiologies of recurrent colic and primarily focus on evidence‐based nutritional management of colonic impactions, sand enteropathy, inflammatory bowel disease, and idiopathic recurrent colic, which is limited. Additional topics to be covered elsewhere in this series that are relevant to this topic include nutritional management of gastric ulceration, liver disease, colitis, geriatric horses, and feeding the horse pre‐ and post surgery.     

Comparison of three methods for arthrodesis of the distal intertarsal and tarsometatarsal joints in horses

OBJECTIVE: To evaluate the effects of diode laser surgery (LS), surgical drilling (SD), and intraarticular sodium monoiodoacetate (MIA) as methods for fusing the distal intertarsal (DIT) and tarsometatarsal (TMT) joints in horses. STUDY DESIGN: Experimental study. ANIMALS: Adult horses (15) without radiographic signs of osteoarthritis (OA) of the DIT and TMT joints. METHODS: Group 1 (n=3) had LS performed bilaterally on DIT and TMT joints; 1 horse was evaluated for 1 week and 2 horses were evaluated for 2 weeks. Group 2 (n=6) had LS on DIT and TMT joints of 1 tarsus and MIA administration into the contralateral DIT and TMT joints and were evaluated for 6 months. Group 3 (n=6) had LS performed on DIT and TMT joints of 1 tarsus and SD of the contralateral DIT and TMT joints and were evaluated for 12 months. Postoperative comfort, lameness, radiography, microradiography, and histology scores were compared using repeated measures ANOVA, and paired or 2 sample t-tests; significance was set at P<.05. RESULTS: LS caused the least postoperative morbidity. In group 2, horses were less lame in 4 LS-treated limbs and 2 MIA-treated limbs at 6 months when compared with the contralateral limb. In group 3, horses were less lame in 5 LS-treated limbs and 1 SD-treated limb at 6 and 12 months compared with the contralateral limb. On microradiography, 11 MIA joints and 2 LS joints had bone bridging the joint at 6 months whereas 8 SD joints and 5 LS joints had bone bridging at 12 months. Significantly more joint space was bridged by bone in MIA- (51.4%) and SD (46.2%)-treated joints compared with LS joints at 6 (30.6%) and 12 (28.5%) months, respectively (P<.05). CLINICAL RELEVANCE: SD and MIA resulted in more bone bridging of the distal 2 tarsal joints, than LS. However, LS seemingly caused less pain and discomfort to horses in the immediate postoperative period; horses were generally less lame in the LS limb. More laser energy may need to be applied to these joints to promote fusion; however, it may also have beneficial effects beyond fusion. Further research on horses with OA of the distal 2 tarsal joints is needed to determine whether LS can cause soundness without facilitating bony fusion.     

Equine piroplasmosis: An updated review

Equine piroplasmosis (EP) is a tick‐borne protozoal disease. The causative agents are Babesia caballi and Theileria equi. Horses infected with T. equi remain carriers for life. Iatrogenic means can also be factors for transmission. Typical clinical signs of acute EP can include fever, anorexia, anaemia, icterus, congested mucous membranes, tachypnoea and tachycardia, sweating, and limb and supraorbital oedema. In severe cases, haemoglobinuria and bilirubinuria are present as well as a variety of atypical presentations due to organ damage and dysfunction. Because clinical pathology is not specific of EP, accurate diagnosis requires specific diagnostic tests. The value and the pertinence of blood smears, polymerase chain reaction and serological tests are presented. Imidocarb propionate is considered as the drug of choice against EP. However, treatment strategies differ greatly between endemic and nonendemic regions. In endemic regions the goal is to reduce clinical disease because premunition plays an important role in the protection of horses, while in nonendemic regions the goal of treatment is to eliminate the risk of transmission with sterilising treatment protocols. As there is no effective vaccine available to date, prevention relies mainly on drug therapy, restriction in the movement of infected horses, and control of tick vectors.     

Practical usefulness of a therapeutic soft contact lens for a corneal ulcer in a racehorse

Therapeutic soft contact lenses (TSCL) were applied to a thoroughbred racehorse with corneal ulcer refractory to topical medication. The insertion of the TSCL was conducted on day 36 using a nose twitch under sedation, auriculopalpebral nerve block, and topical anesthesia. The lens was retained, with the duration of wear lasting 114 days. Ocular pain improved immediately and fluorescein tests were negative 17 days after insertion. The horse was able to undergo training and ran in two races while wearing the TSCL. Thus a TSCL was found to be clinically useful for treating corneal ulcers in racehorses.